Otolaryngology and Hearing Disorders
AudioCure Pharma GmbH focuses on idiopathic sudden sensorineural hearing loss, with clinical research centered on the restoration of auditory function and the management of acute inner-ear injury. Its work is directed toward patients with moderately-severe to profound hearing loss and the evaluation of hearing recovery outcomes.
- Sudden sensorineural hearing loss
- Inner-ear hearing impairment
- Auditory threshold recovery
- Pure tone audiometry
The sponsor’s clinical activity is concentrated in hearing medicine and the treatment of acute auditory dysfunction, with research sites distributed across multiple European countries.
Middle Ear Therapeutics
Clinical interest extends to middle ear delivery approaches for hearing loss, reflecting a therapeutic focus on localized treatment of the auditory system. The funded research compares a single injection administered into the middle ear with an oral treatment option in the setting of sudden hearing loss.
- Middle ear administration
- Localized otic treatment
- Acute hearing restoration
This area highlights the sponsor’s involvement in therapies intended to address the affected ear directly in otologic disease.
Audiometric Outcome Assessment
Research activity includes measurement of hearing improvement through auditory threshold changes and frequency-specific testing. The clinical focus is on objective assessment of hearing performance after treatment in patients with sudden hearing loss.
- Hearing threshold change
- Frequency-based hearing testing
- Objective auditory assessment
These interests place emphasis on audiology as a core domain within the sponsor’s clinical research portfolio.
Safety and Tolerability in Ear Disease
The sponsor also investigates safety and tolerability in the context of treatment for sudden hearing loss, with attention to how therapies are used in patients experiencing acute auditory impairment.
- Therapeutic safety
- Tolerability evaluation
- Acute otologic treatment
This reflects a medical interest in ensuring that interventions for sensorineural hearing loss are suitable for use in the clinical management of ear-related disease.
